Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.900 | 0.953 | 43 | 2007 | 2019 | |||||
Malignant neoplasm of breast
|
3417 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.800 | 0.950 | 40 | 2007 | 2019 | |||||
Nasopharyngeal carcinoma
|
320 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||
Neoplasms
|
1644 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.030 | 1.000 | 3 | 2011 | 2018 | |||||
Carcinoma of Male Breast
|
38 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||
Familial (FPAH)
|
276 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.020 | 1.000 | 2 | 2014 | 2016 | |||||
Malignant neoplasm of male breast
|
43 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||
Secondary malignant neoplasm of bone
|
18 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.020 | 0.500 | 2 | 2007 | 2012 | |||||
Breast Fibrocystic Disease
|
12 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Carcinoma of lung
|
1204 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
estrogen receptor-negative breast cancer
|
40 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Hyperlipidemia
|
83 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Malignant neoplasm of lung
|
1142 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of ovary
|
315 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Malignant neoplasm of stomach
|
615 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Mammary Neoplasms
|
385 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1 | 2016 | 2016 | ||||||
Miscarriage
|
56 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1 | 2019 | 2019 | ||||||
ovarian neoplasm
|
757 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Primary malignant neoplasm of lung
|
981 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Stage 0 Breast Cancer AJCC v6 and v7
|
8 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Stage 0 Breast Carcinoma
|
8 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Stomach Carcinoma
|
652 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Triple Negative Breast Neoplasms
|
99 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Triple-Negative Breast Carcinoma
|
96 | 0.662 | 0.440 | 16 | 52552429 | non coding transcript exon variant | A/G | snv | 0.63 | 0.010 | 1.000 | 1 | 2011 | 2011 |